comparemela.com

Page 7 - Kurma Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Xeltis Secures Additional €12 5M in Final Close of D2 financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Eliane schutteLife sciencesPharma groupDavita venture groupEuropean innovation councilKurma partnersYsios capitalGrand pharma group

Flamingo Therapeutics Receives €1 7M Grant Award from VLAIO

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Region flamandeIonis pharmaceuticalsTekla capital managementFlamingo therapeuticsFlanders innovationAndera partnersBpifrance large ventureFonds biothMaladies raresKurma partnersPerceptive advisors

Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress

Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress aXess graft demonstrated excellent patency

United statesAmber fennell chris welshEliane schutteMatteo tozziAlexander goemansDavita venture groupConsilium strategic communicationsVascular access society congressLife sciencesPharma groupUniversity of insubriaVascular access society in portoVascular access societyVascular surgeryXess vascular graftKidney disease

Kiro Raises €13 8M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

France generalAlexandre guenounSofinnova partnersFonds ambition amorKurma partners

Sofinnova Partners dives into digital medicine

European life sciences venture capital firm Sofinnova Partners, has launched a new investment strategy focused on digital medicine.

City ofUnited kingdomFrance generalEdward kliphuisNik sharmaSimon turnerAntoine papiernikAlexandre guenounSofinnova partnersDigital medicineSofinnova digital medicine strategySofinnova digital medicineSofinnova partner digital medicineFonds ambition amorcage angelsKurma partnersPropulia capital

vimarsana © 2020. All Rights Reserved.